Continuous Glucose Monitoring Following Hospital Discharge

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 108 participants.

Also called NCT05360056

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 108 participants (enrolled count) (from the registry)
Sponsor
  • DexCom, Inc. Registry lists this organization as a collaborator
Registry
  • NCT NCT05360056
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05360056. Allocation not applicable; no masking; primary purpose treatment. Start 2022-04-26 (actual); primary completion 2024-08-31 (actual). Results posted on 2025-12-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Continuous Glucose Monitoring Following Hospital Discharge
Intervention (Device)
DexCom G6
Lead sponsor
Kathleen Dungan (class: other)
Collaborator
DexCom, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05360056
Content hash
e6710844e8eeb5a88c29d346a30d2db2aa430a31ddf69c823c2eb55d86d465ab